MetaCap

Dianthus Therapeutics Inc. Company Profile

NASDAQ: DNTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD

84.55-0.28 (-0.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Dianthus Therapeutics at a glance

Dianthus Therapeutics Inc. (NASDAQ: DNTH) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New York, NY. Dianthus Therapeutics is led by Mr. Marino Garcia M.B.A. and employs about 92 people. The company's shares have traded publicly since 2018.

At a market capitalization of $4.78 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001690585, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Dianthus Therapeutics do?

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

Business description based on the company's public filings.

Company information

Legal name
Dianthus Therapeutics Inc.
Ticker
NASDAQ: DNTH
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Marino Garcia M.B.A.
Employees
92
Headquarters
7 Times Square, New York, NY, United States
Phone
929 999 4055
IPO year
2018
SEC CIK
0001690585
Latest annual report
10-K · Mar 9, 2026

Companies similar to Dianthus Therapeutics

DNTH peer companies
CompanyPrice% ChgMarket capCompare
ERASErasca Inc.13.61-4.29%$4.78Bvs DNTH
PTCTPTC Therapeutics Inc.56.42-3.27%$4.71Bvs DNTH
LQDALiquidia Corporation54.43-3.88%$4.90Bvs DNTH
COGTCogent Biosciences Inc.26.72-3.69%$4.65Bvs DNTH
TVTXTravere Therapeutics Inc.47.00-2.69%$4.51Bvs DNTH
MANEVeradermics Incorporated119.52-3.92%$5.04Bvs DNTH
IONSIonis Pharmaceuticals Inc.26.58-2.35%$4.43Bvs DNTH
BLTEBelite Bio Inc ADR127.38-15.65%$5.17Bvs DNTH

Related